Key Takeaways CeriBell gained FDA clearance for its continuous EEG-based delirium monitoring solution.The system delivers real-time EEG insights to cut clinical variability and aid earlier delirium detection.Tested on 225 adults, the algorithm builds on prior Breakthrough status and ties to a CMS NTAP bid.CeriBell Inc. (CBLL) recently announced that the FDA has given 510(k) clearance for its latest delirium monitoring solution, making it the one and only FDA-cleared solution for continuous tracking of delir ...